Bibliografia UJ CM

1/10
Meletios A. Dimopoulos, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Bjorn E. Wahlin, Ramon Garcia-Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernandez de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Steven P. Treon, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Heather Allewelt, Sheel Patel, Aileen Cohen, Constantine S. Tam.
Zanubrutinib versus ibrutinib in symptomatic Waldenström macroglobulinemia : final analysis from the randomized phase III ASPEN study
Journal of Clinical Oncology
2023, il., bibliogr. 16 poz., abstr.
Autor korespondencyjny: Meletios A. Dimopoulos
Online First 2023-07-21
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
XXX
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
2/10
Larry W. Kwak, Juan-Manuel Sancho, Seok-Goo Cho, Hideyuki Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim, Tobias Menne, Jose Mariz, Nikolai Ilyin, Wojciech Jurczak, Aurelio Lopez Martinez, Olga Samoilova, Edvard Zhavrid, Eduardo Yanez Ruiz, Marek Trneny, Leslie Popplewell, Michinori Ogura, Won-Seog Kim, Sang Joon Lee, Sung Hyun Kim, Keum Young Ahn, Christian Buske.
Efficacy and safety of CT-P10 versus rituximab in untreated low-tumor-burden follicular lymphoma : final results of a randomized phase III study.
Clinical Lymphoma, Myeloma and Leukemia
2022 : Vol. 22, nr 2, s. 89-97, il., bibliogr. 24 poz., abstr.
Autor korespondencyjny: Christian Buske.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 2152-2650
e-ISSN: 2152-2669
AZ
ORG
AIF
IF: 2.700
Adres url:
Streszczenie w PubMed:
3/10
Constantine S. Tam, Jennifer R. Brown, Brad S. Kah, Paolo Ghia, Giannopoulo Giannopoulos, Wojciech Jurczak, Martin imkovič, Mazyar Shadman, Anders Österborg, Luca Laurenti, Patricia Walker, Stephen Opat, Henry Chan, Hanna Ciepluch, Richard Greil, Monica Tani, Marek Trneny, Danielle M. Brander, Ian W. Flinn, Sebastian Grosicki, Emma Verner, Alessandra Tedeschi, Jianyong Li, Tian Tian, Lei Zhou, Carol Marimpietri, Jason C. Paik, Aileen Cohe, Jane Huang, Tadeusz Robak, Peter Hillmen.
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA) : a randomised, controlled, phase 3 trial.
Lancet. Oncology
2022 : Vol. 23, nr 8, s. 1031-1043, il., bibliogr. 31 poz., sum.
Autor korespondencyjny: Tadeusz Robak, Peter Hillmen.
p-ISSN: 1470-2045
e-ISSN: 1474-5488
AZ
ORG
AIF
IF: 51.100
Adres url:
Streszczenie w PubMed:
4/10
Constantine S. Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton Marlton, Björn E. Wahlin, Ramon Garcia Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernandez de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Sunhee Ro, Aileen Cohen, Jane Huang, Meletios Dimopoulos.
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia : the ASPEN study.
Blood
2020 : Vol. 136, nr 18, s. 2038-2050, il., bibliogr. 39 poz., abstr.
Auto korespondencyjny: Constantine S. Tam.
p-ISSN: 0006-4971
AZ
ORG
AIF
IF: 22.113
Adres url:
Streszczenie w PubMed:
5/10
Michinori Ogura, Juan Manuel Sancho, Seok-Goo Cho, H. Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim, Anne Lennard, Jose Mariz, Nikolai Ilyin, Wojciech Jurczak, Aurelio Lopez Martinez, Olga Samoilova, Edvard Zharvid, Eduardo Yanez Ruiz, Marek Trneny, Leslie Popplewall, Bertrand Coiffier, Christian Buske, Won-Seog Kim, Sang Joon Lee, Sung Young Lee, Jun Ju Bae, Larry W. Kwak.
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial.
Lancet. Haematology
2018 : Vol. 5, nr 11, s. e543-e553, il., bibliogr.
Autor korespondencyjny: Larry W. Kwak.
p-ISSN: 2352-3026
AZ
ORG
AIF
IF: 11.990
Adres url:
Streszczenie w PubMed:
DOI:
6/10
Luca Arcaini, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon Rule, Jose Cabecadas, Elias Campo, Stefano A. Pileri, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo, Marek Trneny.
Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma
British Journal of Haematology
2018 : Vol. 180, nr 2, s. 224-235, il., bibliogr., sum.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
Autor korespondencyjny: Luca Arcaini.
p-ISSN: 0007-1048
AZ
ORG
AIF
IF: 5.206
Adres url:
Streszczenie w PubMed:
7/10
Martin Dreyling, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Marek Trneny, Fritz Offner, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, Georg Hess, Isabelle Bence-Bruckler, Seok-Goo Cho, John Bothos, Jenna D. Goldberg, Christopher Enny, Shana Traina, Sriram Balasubramanian, Nibedita Bandyopadhyay, Steven Sun, Jessica Vermeulen, Aleksandra Rizo, Simon Rule.
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Lancet
2016 : Vol. 387, nr 10020, s. 770-778, il., bibliogr. 29 poz., sum.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 47.831
Adres url:
Streszczenie w PubMed:
8/10
Marek Trneny, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, John Radford, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon Rule, Boris Afanasyev, Kamil Kaplanov, Antoine Thyss, Alexej Kuzmin, Sergey Voloshin, Kazimierz Kuliczkowski, Agnieszka Giza, Noel Milpied, Caterina Stelitano, Reinhard Marks, Lorenz Trumper, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo, Casadebaig Bravo, Luca Arcaini.
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.
Lancet. Oncology
2016 : Vol. 17, nr 3, s. 319-331, il., bibliogr. 28 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
Streszczenie w PubMed:
9/10
Marek Trneny, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, John A. Radford, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon A. Rule, Boris V. Afanasyev, Kamil Kaplanov, Antoine Thyss, Alexej Kuzmin, Sergey Voloshin, Kazimierz Kuliczkowski, Agnieszka Giza, Noel Milpied, Caterina Stelitano, Reinhard Marks, Lorenz Trumper, Tsvetan Biyukov, Evelyn Barnett, Marie-Laure Casadebaig Bravo, Luca Arcaini.
Outcomes Following Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma Patients at Risk of Bleeding Events Because of Multiple Comorbidities or Treatment: A Post-Hoc Subgroup Analysis of the SPRINT (MCL-002) Trial.
Blood
2016 : Vol. 128, nr 22, s. 2978
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
10/10
Martin Dreyling, Eva Hoster, Silvia Bea, Elena Hartmann, Heike Horn, Grit Hutter, Itziar Salaverria, Christiane Pott, Marek Trneny, Steven Le Gouill, Sergio Cortelazzo, Michal Szymczyk, Wojciech Jurczak, Ofer Sphilberg, Vincent Ribrag, Olivier Hermine.
Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL) : minutes of the 9th European MCL Network conference.
Leukemia & Lymphoma
2010 : Vol. 51, nr 9, s. 1612-1622, bibliogr. 36 poz.
AZ
POG
AIF
IF: 2.492
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ